İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2023

Evaluation of upper gastrointestinal system endoscopy screening in patients with acromegaly: a single center experience

CUKUROVA MEDICAL JOURNAL

YÖKSİS OpenAlex Açık erişim · diamond JCR Q3 TR Index Atıf 0 Yüzdelik 5.2% FWCI 0.0
Yıl
2023
ISSN
2602-3032
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

Purpose: The prevalence of precancerous or cancerous lesions in the upper gastrointestinal tract in acromegalic patients is not well known. The aim of this study is to evaluate the endoscopic findings of the upper gastrointestinal system (GIS) of patients with acromegaly and to assess whether the pathological findings are related to the disease and the use of somatostatin analogs. Materials and Methods: Between January 2010 and October 2021, patients diagnosed with acromegaly were identified by retrospective medical record scanning. This study included 49 patients with acromegaly who underwent upper GIS endoscopy. The acromegaly patients were divided into two groups: those who were taking somatostatin analogs at the time of endoscopy and those who were not. It was investigated whether there was a difference between these two groups in terms of lesion development. The patients with acromegaly and the control group were compared in terms of endoscopic findings and biopsy results. Results: Of these patients, 53% (n=26) were male and 46.9% (n=23) were female. The incidence of Helicobacter pylori (HP) was significantly higher in the acromegaly patients than in the control subjects. In the acromegaly group, 62.5% (n=15) of the 24 patients with antral and pangastritis were taking somatostatin analogs. There was no significant difference between the use of somatostatin analogs and the development of gastritis. The development of esophagitis was statistically higher in patients with acromegaly taking somatostatin analogs. Conclusion: The incidence of HP was higher in patients with acromegaly than in the normal population. No clear results were found regarding the development of gastritis. The incidence of esophagitis was high in acromegalic patients taking somatostatin analogs. Large-scale studies are needed to uncover the relationship between the etiology of the disease and the drugs taken.

Konular

  • Pituitary Gland Disorders and Treatments
  • Neuroendocrine Tumor Research Advances
  • Gastrointestinal Tumor Research and Treatment

Birincil konu Pituitary Gland Disorders and Treatments

Yazarlar

  1. YASEMİN EMÜR GÜNAY GİRESUN ÜNİVERSİTESİ
  2. SERDAR DURAK
  3. ÖZGE ÜÇÜNCÜ KARADENİZ TEKNİK ÜNİVERSİTESİ
  4. ARİF MANSUR COŞAR